Skip to content Skip to footer
Subscribe Now
Spotlight Interview_Bruce Bauer & Kendall Morrison
CXO TALKS

Spotlight Interview with Bruce Bauer (CEO) & Kendall Morrison (CSO) at TAE Life Sciences

PharmaShots conducted its fourth “Spotlight- Company of the Month with TAE Life Sciences”. In conversation with Bruce Bauer (CEO) & Kendall Morrison (CSO) at TAE Life Sciences, they both shared insights on TAE Life Sciences' vision, upcoming plans, technologies used, and developing products. Bruce and Kendall spoke about TAE’s novel treatment options which could potentially…
December 5, 2022

Read more

Viewpoints_Priya Singhal
VIEWPOINTS

Priya Singhal, Senior Vice President at Biogen, Shares Insights from Litifilimab Systemic Lupus Erythematosus NEJM Publication

Shots: Priya spoke about the study design and key findings from the P-II (LILAC), P-III (TOPAZ-1) & (TOPAZ-2) clinical study evaluating litifilimab She also talked about the P-III trial evaluating Dapirolizumab pegol in collaboration with UCB to treat SLE The interview summarizes how Biogen’s innovative medications are helping patients with Systemic Lupus Erythematosus which has…
November 30, 2022

Read more

Viewpoints_Patrick Mooney
VIEWPOINTS

Patrick Mooney, CEO at SpyGlass Pharma, Shares Insights from the 3-Month Data of its Innovative Drug Delivery Platform for Chronic Eye Conditions

Shots: Patrick spoke about the 3-month data from the First-in-Human glaucoma treatment trial of Spyglass’ innovative  drug delivery platform that helps in lowering intraocular pressure in patients with glaucoma or ocular hypertension Patrick also talked about the study design and key findings from the First-in-Human glaucoma treatment trial The interview gives an understanding of Spyglass’…
November 29, 2022

Read more

Viewpoints_Tim Clackson
VIEWPOINTS

Tim Clackson, President & CEO of Theseus Pharmaceuticals, Shares Insights on its Pan-Variant Inhibitor Therapies to Treat Cancer

Shots: Tim spoke about the development of THE-349, a fourth-generation small molecule for the treatment of EGFR-mutant NSCLC Tim also talked about Thesus’ other small molecule, THE-630 in gastrointestinal stromal tumors (GIST) being evaluated in a P-I/II dose-escalation and expansion study  The interview gives an understanding of how Thesus is developing different treatment options to…
November 28, 2022

Read more

Viewpoints_Herson Quiñones
VIEWPOINTS

Herson Quiñones, VP at GSK Shares Insights on the FDA Approval of Benlysta for Pediatric Patients with Active Lupus Nephritis

Shots: Herson spoke about the approval of Benlysta by the US FDA for the treatment of children aged 5 to 17 with active lupus nephritis (LN) which often causes increased complications, hospitalizations, and mortality rates in children He also talked about the etiology & epidemiology of lupus nephritis and how this disease is affecting millions…
November 22, 2022

Read more

Viewpoints_Dr. Navdeep Tangri_Helen Yeh
VIEWPOINTS

Dr. Navdeep Tangri & Helen Yeh Shares Insights from the Data Presented at ASN Kidney Week 2022 on the Importance of Earlier Screening & Diagnosis of Chronic Kidney Disease

Shots: Dr. Navdeep spoke about the data presented at the ASN Kidney Week 2022 emphasizing on the urgent need for early screening of chronic kidney disease Helen Yeh talked about the treatment of CKD with Farxiga. She also focused on the patient support programs by AstraZeneca for the early diagnosis and screening of patients The…
November 21, 2022

Read more

Load more